Deep Genomics Company
Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.
Investors
%20.jpg)
.png)
.png)
Connections
Connections from
Founded Date:
2014
Last Funding Type:
Series C
Headquarters:
Toronto, Ontario, Canada
Investors Number:
15
Employee Number:
101-250
Industry:
Anti-aging Therapies
Estimated Revenue:
$236.7M
Last Funding Date:
2021-07-28
Funding Status:
Late Stage Venture
Total Funding:
236700000